The association of smoking with components of the metabolic syndrome in non-diabetic patients

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 11, 2008, Pages 919-923

  Gharipour, Mojgan ^a   Kelishadi, Roya ^a   Sarrafzadegan, Nizal ^a   Baghaei, Abdolmehdi ^a   Yazdani, Mehrdad ^a   Anaraki, Jafar ^b   Eshrati, Babak ^c   Tavassoli, Ali Akbar ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anthropometric indexes; Biochemical factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 57649200770     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Meigs JB. Epidemiology of the metabolic syndrome. Am J Manag Care 2002;8:S283-S92.
2. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-52.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
4. Kelishadi R, Derakhshan R, Sabet B, Sarrafzadegan N, Kahbazi M, Sadri GH, et al. The metabolic syndrome in hypertensive and normotensive subject: The Isfahan Healthy Heart programme. Ann Acad Med Singapore 2005;34:243-9.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
6. Kannel WB, McGee DL, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.
7. Wood D. Established and emerging cardiovascular risk factors. Am Heart J 2001;141:49-57.
8. Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Toutouzas PK. Risk stratification of coronary heart disease through established and emerging lifestyle factors, in a Mediterranean population: CARDIO2000 Epidemiological Study. J Cardiovasc Risk 2001;6:329-39.
9. Tsujii S, Kuzuya H. The significance of lifestyle as a risk factor for the metabolic syndrome Nippon Rinsho 2004;62:1047-52.
10. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996;51:348.
11. Marangon K, Herbeth B, Lecomte E, Paul-Dauphin A, Grolier P, Chancerelle Y, et al. Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 1998;67:231-9.
12. Cross CE, Van der Vliet A, Eiserich JP. Cigarette smokers and oxidant stress: a continuing mystery. Am J Clin Nutr 1998;67:184-5.
13. Cia H, Harrison DG. Endothelial in cardiovascular disease the role of oxidant stress. Circ Res 2000;87:840-4.
14. Sarraf-zadegan N, Sadri G, Malek Afzali H, Baghaei M, Mohammadifard N, Shahrokhi S, et al. Isfahan Healthy Heart programme: a comprehensive integrated community-bases programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cordial 2003;58:309-20.
15. Kim SH, Kim JS, Shin HS, Keen CL. Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition 2003;19:240-3.
16. Guthikonda S, Sinkey C, Barenz T, Haynes WG. Xanthine oxidase reverses endothelial dysfunction in heavy smokers. Circulation 2003;107:416-21.
17. Winkelmann BR, Boehm BO, Nauck M. Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease. Curr Med Res Opin 2001;17:132-41.
18. Shimokata H, Muller DC, Anders R. studies in the distribution of body fat, III. Effect of cigarette smoking. JAMA 1989;261:1169-73.
19. Freund KM, Belanger AJ, Agostino DRB, Kannel WB. The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol 1993;3:417-24.
20. Reaven G. Metabolic syndrome: pathophysiology and implication for management of cardiovascular disease. Circulation 2002;106:286-8.
21. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance an cigarette smoking. Lancet 1992;339:1128-30.
22. Okubo Y, Suwazono Y, Kobayashi E, Nogawa K. An association between smoking habits and blood pressure in normotensive Japanese men: a 5-year follow-up study. Drug Alcohol Depend 2004;73:167-74.
23. Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K. The influence of smoking and smokeless tobacco use on weight amongst men. J Intern Med 2004;255:102-7.
24. Tahtinen TM, Vanhala MJ, Oikarinen JA, Keinanen-Kiukaaniemi SM. Effect of smoking on the prevalence associated cardiovascular risk factors of insulin resistance among Finnish men in military service. J Cardiovasc Risk 1998;5:319-23.
25. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
26. International Obesity Task Force. Asia-Pacific Perspective: Redefining Obesity and its Treatment. Western Pacific Region. Sydney: Health Communications, 2000.
27. Tahtinen TH, Vanhala MJ, Oikarinen JA, Keinanen-Kiukaanniemi SM. Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J Cardiovasc Risk 1998;5:319-23.